ISBA vs RARE · P/E 15, rev $51.3M vs rev $350.0M
Isabella Bank Corporation (ISBA) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Isabella Bank Corporation (ISBA) is a banks - regional company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported ISBA revenue for 2026-06-30 was $51.3M. Net income was $10.0M. ISBA currently screens at market cap $211.1M and trailing P/E 14.5.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
ISBA currently screens at market cap $211.1M and trailing P/E 14.5. RARE currently screens at market cap $2.79B.
Not investment advice. Open the ISBA and RARE stock pages for the full models.
Not investment advice.